MedTech Market in France Hits €37B: Innovation and Global Ties Grow 

With a staggering market value of €37.4 billion and over 1,300 companies in operation, France’s MedTech sector is not just thriving, it’s transforming the future of healthcare in Europe and beyond. According to the U.S. International Trade Administration, the French medical device industry is the second-largest in Western Europe, trailing only Germany. Exports alone reached €9.5 billion in 2023, representing 25% of total turnover. 

And the momentum is only building. 

A Thriving, Innovation-Focused Ecosystem 

The MedTech landscape in France is dominated by small and medium-sized enterprises (SMEs), with 92% of companies falling into this category. Interestingly, foreign-owned firms make up a third of all enterprises in the sector but generate two-thirds of its revenue—a clear sign of the international attractiveness of the French market. 

Approximately 95,000 people are employed across the industry, which spans diagnostics, surgical robotics, imaging technologies, and implantable devices. Paris, Lyon, and Grenoble have emerged as regional innovation hubs, powered by partnerships between startups, hospitals, and public research institutions such as INSERM, CNRS, and the CEA. 

Government support has also played a pivotal role. Under the ambitious €54 billion France 2030 investment plan, €7.5 billion is being funneled into the health sector. This includes targeted investments in artificial intelligence, digital health, and robotic surgery, aiming to make France a global reference point in cutting-edge medical technologies. 

Also Read: Calling All MedTech Innovators: It’s Time to Nominate for MedTech Malta 2025 Awards

Strengthening Global Ties: MedTech World x LallianSe x MD101 

France’s growing role in the MedTech sector is gaining global recognition, reflected in MedTech World’s recent partnerships with LallianSe and MD101. These collaborations aim to connect French innovation with international investment, industry expertise, and opportunities for global scaling.

“Our partnership with LallianSe and MD101 is a testament to our mission of nurturing meaningful innovation in healthcare,” says Dr. Dylan Attard, CEO of MedTech World. “By combining our global MedTech network with LallianSe’s local knowledge and execution power and MD101’s network and market expertise, we’re opening doors for startups to reach new markets and create global health impact.” 

Julie Rachline, founder and CEO of LallianSe, echoes the sentiment: “France has been leading innovation in healthcare in the past decades – surgery, robotics, AI among others. We have been amazingly good at innovating, but we need to improve our scaling and international outreach. Bringing our innovations into a global MedTech market is mandatory. That’s our goal with LallianSe, and that’s a key reason why this partnership with MedTech World and MD101 is so meaningful! MedTech World brings a platform for international visibility and scale. Together, we are accelerating the translation of patient-driven solutions from ideas to reality.” 

Mathieu Charleux, CEO of MD101, emphasized: “This partnership creates a powerful ecosystem where innovation, expertise, and market access converge. LallianSe brings together France’s most promising MedTech innovators, while Medtech World provides the global platform for visibility and connection. MD101 complements this perfectly by transforming those innovations into market-ready solutions—we architect scalable business models, navigate complex regulatory landscapes, and orchestrate international expansion strategies. Together, we’re not just supporting individual companies; we’re building a comprehensive pipeline that takes French MedTech from breakthrough concept to worldwide commercial success.” 

This triad of expertise, MedTech World’s global platform, LallianSe’s integrator and original model, and MD101’s regulatory and go-to-market precision, marks a pivotal step in supporting high-potential health technologies from concept to successful international commercialization. 

Up next: MedTech World Europe 2026 | Malta

MedTech World returns to Malta for MedTech World Europe 2026, its biggest edition yet. Taking place from 11-13 November 2026, MedTech Malta Week expands the traditional conference into a five-day experience across Malta and Gozo, bringing together investors, founders, healthcare leaders, innovators, and industry experts from across the global MedTech ecosystem.

The week opens with the MedTech World Investors Retreat in Gozo from 9–11 November, offering accredited investors and senior industry leaders an exclusive setting for strategic conversations, networking, workshops, and curated experiences. The programme then moves to Malta for a cultural immersion day in Valletta and Mdina on 11 November, before the main MedTech World Europe conference takes place from 11 to 13 November at the Mediterranean Conference Centre in Valletta.

Throughout the conference, attendees can expect keynote sessions, panel discussions, workshops, company showcases, investor meetings, an exhibition floor, and the MedTech World Startup Pitch Competition, followed by the MedTech World Gala Awards, honoring achievements across the global MedTech ecosystem.

Interested in being part of the biggest MedTech World Europe yet? Book your ticket now.